Close Menu

SEATTLE (GenomeWeb) – A new analysis from Invitae suggests a significant proportion of informative, pathogenic cancer risk variants may be missed by focusing germline genetic tests in cancer patients on relatively few genes with potential ties to an individual's cancer type.

Invitae's Edward Esplin outlined results from the study during a session on cancer risk assessment and management at the American College of Medical Genetics and Genomics annual meeting here on Friday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.